ELMD · Electromed, Inc. · Metrics
Market Cap
$230.15M
Shares
8.37M
ELMD metrics
78 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$27.07
Market cap
$230.15M
Price action
20 metricsPrice change (1W)
+1.5%
Price change (30D)
-35.4%
Price change (3M)
-24.2%
Price change (6M)
+16.0%
Price change (YTD)
-5.5%
Price change (1Y)
+10.2%
Trailing year
Price change (5Y)
+105.3%
52-week high
$46.31
52-week low
$23.15
Change from 52-week high
-40.6%
Change from 52-week low
+18.8%
Annualized volatility
52.6%
Annualized volatility (3M)
53.9%
Beta
0.7
RSI (14D)
22.9
Price vs SMA 50
-30.4%
Price vs SMA 200
-12.5%
Avg volume (3M)
104,110
Relative volume
0.8
Average dollar volume
$4.07M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
8.37M
Valuation
12 metricsP / E (TTM)
21.2
Trailing earnings · reciprocal yield 4.7%
PEG ratio
0.5
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.1×
reciprocal yield 32.1%
P / book
4.3
reciprocal yield 23.5%
FCF yield
3.7%
TTM · current market cap
Buyback yield
1.7%
P / FCF
27.4
reciprocal yield 3.7%
P / operating cash flow
23.8
reciprocal yield 4.2%
Earnings yield
4.9%
Historical valuation
8 metricsP / E historical average (3Y)
28.9×
reciprocal yield 3.5%
P / E historical average (5Y)
34.8×
reciprocal yield 2.9%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-25
Profitability
9 metricsGross margin
78.5%
Operating margin
18.8%
Trailing 12 months
Net margin
15.3%
Gross profit (TTM)
$57.94M
Operating profit (TTM)
$13.88M
Net income (TTM)
$11.30M
Trailing 12 months
Diluted EPS (TTM)
$1.30
FCF margin
11.4%
Effective tax rate
21.3%
Growth
11 metricsRevenue growth YoY
+11.6%
Year over year
Net income growth YoY
+54.3%
Revenue (TTM)
$73.78M
Trailing 12 months
EPS growth YoY
+46.2%
Shares change YoY
-3.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+15.4%
Revenue CAGR (5Y)
+15.6%
EPS CAGR (3Y)
+53.4%
EPS CAGR (5Y)
+36.9%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+24.7%
Quality
14 metricsReturn on equity
20.9%
Return on assets
17.1%
Debt / equity
—
Current ratio
4.7
EBITDA (TTM)
—
Free cash flow (TTM)
$8.41M
Quick ratio
4.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$20.45M
Total assets
$66.27M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$9.66M
Capital expenditures (TTM)
$1.25M
R&D (TTM)
$1.31M
SG&A (TTM)
$42.75M
Stock compensation (TTM)
$2.72M
R&D / revenue
1.8%
Stock compensation / revenue
3.7%
Ownership (13F)
3 metrics13F filers
129
13F filer change QoQ
+26
Institutional ownership
55.5%
Short interest
3 metricsShort interest
2.3%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
48 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1488917
CUSIP
285409108
13F (30d)
81 filings
79 filers
Visit website
Investor relations